2008-07-02 14:07:18 - www.companiesandmarkets.com adds new report ...

Cougar Biotechnology is a development stage biopharmaceutical company engaged in acquiring and developing products for the treatment of cancer. The company has built its development portfolio through in-licensing product candidate strategy. The company´s CB-1089 (Seocalcitol), an analog of Vitamin D being studied at pre-clinical stage for the potential treatment of hormone refractory prostate cancer. PR-Inside.com announces the start of the news alerts free service. A great way to stay informed with the latest news of any category. We will email you up to five times daily or immediately when your subject related releases go online. Type any number of key words. If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Originally from: http://www.pr-inside.com/cougar-biotechnology-inc-premium-company-r680261.htm

22.7.08 10:58

bisher 0 Kommentar(e)     TrackBack-URL

E-Mail bei weiteren Kommentaren
Informationen speichern (Cookie)

Die Datenschuterklärung und die AGB habe ich gelesen, verstanden und akzeptiere sie. (Pflicht Angabe)

 Smileys einfügen